Preclinical News and Research

RSS
Study provides important details for recently identified target in lung adenocarcinoma

Study provides important details for recently identified target in lung adenocarcinoma

Arcturus Therapeutics closes $1.3 M in seed funding round

Arcturus Therapeutics closes $1.3 M in seed funding round

Phase I/II study shows safety and efficacy of VB-111 in patients with rGBM

Phase I/II study shows safety and efficacy of VB-111 in patients with rGBM

Combination of ipilimumab and nivolumab drugs reduces tumor size in metastatic melanoma patients

Combination of ipilimumab and nivolumab drugs reduces tumor size in metastatic melanoma patients

RPCI, Jasco Pharmaceuticals partner to advance development of cancer therapy

RPCI, Jasco Pharmaceuticals partner to advance development of cancer therapy

Alios begins oral dosing of ALS-8176 in Phase 1 clinical trial for RSV infection

Alios begins oral dosing of ALS-8176 in Phase 1 clinical trial for RSV infection

Ruthenium complexes could pave way for cancer treatments, say UT Arlington researchers

Ruthenium complexes could pave way for cancer treatments, say UT Arlington researchers

Gene therapy techniques show promise in promoting growth of skin, bone and other tissues

Gene therapy techniques show promise in promoting growth of skin, bone and other tissues

Targacept initiates TC-5214 Phase 2b clinical study in patients with OAB

Targacept initiates TC-5214 Phase 2b clinical study in patients with OAB

Resolvins may help protect against cognitive decline after surgery

Resolvins may help protect against cognitive decline after surgery

Frutarom reports increased demand for natural ingredient targeting urinary incontinence in adults

Frutarom reports increased demand for natural ingredient targeting urinary incontinence in adults

Liposomal anthracycline-based chemotherapy effective for children with leukemia: Study

Liposomal anthracycline-based chemotherapy effective for children with leukemia: Study

Spring Bank Pharmaceuticals starts Phase I study of SB 9200 for treatment of HCV infection

Spring Bank Pharmaceuticals starts Phase I study of SB 9200 for treatment of HCV infection

Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

OncoGenex plans to initiate OGX-42 Phase 2 trial in patients with advanced squamous cell lung cancer

OncoGenex plans to initiate OGX-42 Phase 2 trial in patients with advanced squamous cell lung cancer

Cancer experts to discuss latest developments and implications of cell therapies in oncology

Cancer experts to discuss latest developments and implications of cell therapies in oncology

GUVAX reports successful results in phase I study of oral, Escherichia coli diarrhea vaccine

GUVAX reports successful results in phase I study of oral, Escherichia coli diarrhea vaccine

Newly discovered immune protein has potential  to stop or reverse type 1 diabetes

Newly discovered immune protein has potential to stop or reverse type 1 diabetes

Multiple studies examine ideal biomarkers for Huntington's disease

Multiple studies examine ideal biomarkers for Huntington's disease

Honokiol protects muscles from normal inflammation caused by intense exercise

Honokiol protects muscles from normal inflammation caused by intense exercise

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.